| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0091 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |